The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
X chromosome-linked muscular dystrophy (mdx) in the mouse
Open accessAbstract
An X chromosome-linked mouse mutant (gene symbol, mdx) has been found that has elevated plasma levels of muscle creatine kinase and pyruvate kinase and exhibits histological lesions characteristic of muscular dystrophy. The mutants show mild clinical symptoms and are viable and fertile. Linkage analysis with four X chromosome loci indicates that mdx maps in the Hq Bpa region of the mouse X chromosome. This gives a gene order of mdx-Tfm-Pgk-1-Ags, the same as for the equivalent genes on the human X chromosome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mdx (dystrophin deficient) mouse model has a rather mild cardiomyopathy, mild limb-skeletal muscle dysfunction, and a normal life span, in contrast to human counterparts”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Bulfield, et al., 1984
In the citing paper
“The most widely used animal model for DMD, the mdx mouse, exhibits only a mild dystrophic phenotype, although like DMD patients, it lacks functional dystrophin due to a point mutation in the dystrophin gene (Bulfield et al., 1984; Hoffman et al., 1987; Ryder-Cook et al., 1988).”
From Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice (2010) · cites this paper as Bulfield et al., 1984
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Murray, J., Davies, K. E., Harper, P. S., Meredith, L., Mueller, C. R., & Williamson, R. (1982) · Nature · doi:10.1038/300069a0 · Cited by 330
ACID HYDROLASES AS MODELS OF GENETIC CONTROL
Paigen, K. (1979) · Annual Review of Genetics · doi:10.1146/annurev.ge.13.120179.002221 · Cited by 233
Kingston, H. M., Thomas, N. S. T., Pearson, P. L., Sarfarazi, M., & Harper, P. S. (1983) · Journal of Medical Genetics · doi:10.1136/jmg.20.4.255 · Cited by 90
Chimaera mouse study shows absence of disease in genetically dystrophic muscle
Peterson, A. C. (1974) · Nature · doi:10.1038/248561a0 · Cited by 59
Serum pyruvate kinase in muscle disease and carrier states
Alberts, M. C., & Samaha, F. J. (1974) · Neurology · doi:10.1212/wnl.24.5.462 · Cited by 54
A histological study of muscle from the bar harbor strain of dystrophic mice
Pearce, G. W., & Walton, J. N. (1963) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700860105 · Cited by 51
Polymorphism of kidney pyruvate kinase in the mouse is determined by a gene, Pk-3, on chromosome 9
Peters, J., Nash, H., Eicher, E. M., & Bulfield, G. (1981) · Biochemical Genetics · doi:10.1007/bf00484007 · Cited by 46
Self-citationPyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction
Harano, Y., Adair, R., Vignos, P. J., Miller, M., & Kowal, J. (1973) · Metabolism · doi:10.1016/0026-0495(73)90041-3 · Cited by 41
Creatine Phosphokinase Isoenzymes in Muscle in human Myopathies
Kar, N. C., & Pearson, C. M. (1965) · American Journal of Clinical Pathology · doi:10.1093/ajcp/43.3.207 · Cited by 40
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Calpain Inhibitors as Therapeutic Agents in Nerve and Muscle Degeneration
Stracher, A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08635.x · Cited by 54
Mini‐dystrophin restores L‐type calcium currents in skeletal muscle of transgenic mdx mice
Friedrich, O., Both, M., Gillis, J., Chamberlain, J. S., & Fink, R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.054213 · Cited by 54
Mofification of body composition by clenbuterol in normal and dystrophic (mdx) mice
Rothwell, N. J., & Stock, M. J. (1985) · Bioscience Reports · doi:10.1007/bf01119873 · Cited by 54
Tang, Y. M., Reay, D. P., Salay, M., Mi, M. Y., Clemens, P. R., D, D. C. G., Robbins, P. D., Huard, J., & Wang, B. (2010) · Gene Therapy · doi:10.1038/gt.2010.110 · Cited by 53
Novak, J., Hogarth, M., Boehler, J. F., Nearing, M., Vila, M., Heredia, R., Fiorillo, A., Zhang, A.-P., Hathout, Y., Hoffman, E., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00924-7 · Cited by 49
Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
Heydemann, A. (2018) · Nutrients · doi:10.3390/nu10060796 · Cited by 43
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
Soblechero‐Martín, P., López‐Martínez, A., Ovejero, L. D. L. P., Vallejo‐Illarramendi, A., & Arechavala‐Gomeza, V. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12735 · Cited by 58
Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
Wilton, S. D., Dye, D. E., Blechynden, L. M., & Laing, N. G. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00058-8 · Cited by 53
Targeting the Immune System to Improve Ventilatory Function in Muscular Dystrophy
Gosselin, L. E., & McCormick, K. M. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000106185.22349.2c · Cited by 53
Antisense-mediated redirection of mRNA splicing
Vacek, M. M., Sazani, P., & Kole, R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3042-7 · Cited by 54
Falzarano, M. S., Passarelli, C., & Ferlini, A. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0450 · Cited by 53
Karpati, G., & Acsádi, G. (1993) · Muscle & Nerve · doi:10.1002/mus.880161102 · Cited by 53
Fan, Z., Wang, J., Ahn, M., Shiloh‐Malawsky, Y., Chahin, N., Elmore, S., Bagnell, C. R., Wilber, K. P., An, H., Lin, W., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.10.005 · Cited by 52
Striational autoantibodies in myasthenia gravis mainly react with ryanodine receptor
Iwasa, K. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199706)20:6 · Cited by 12
Saleh, K. K., Xi, H., Switzler, C., Skuratovsky, E., Romero, M. A., Chien, P., Gibbs, D. E., Gane, L., Hicks, M. R., Spencer, M. J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105415 · Cited by 55
Feron, M., Guével, L., Rouger, K., Dubreil, L., Arnaud, M., Ledevin, M., Megeney, L. A., Chérel, Y., & Sakanyan, V. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080460 · Cited by 52
Ortiz-Vitali, J. L., & Darabi, R. (2019) · Cells · doi:10.3390/cells8010020 · Cited by 51
Stem cell therapy for muscular dystrophy
Sohn, R. L., & Gussoni, E. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.1.1 · Cited by 51
Gene transfer to muscle using herpes simplex virus-based vectors
Huard, J., Krisky, D. M., Oligino, T., Marconi, P., Day, C. S., Watkins, S. C., & Glorioso, J. C. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00054-0 · Cited by 51
Cell and Gene Therapy in Duchenne Muscular Dystrophy
Morgan, J. E. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.2-165 · Cited by 51
Dystrophin is a component of the subsynaptic membrane.
Yeadon, J. E., Lin, H. Y.-F., Dyer, S. M., & Burden, S. J. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.1069 · Cited by 51
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice
Gardan‐Salmon, D., Dixon, J., Lonergan, S. M., & Selsby, J. T. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-1906-3 · Cited by 50
Marshall, J. L., Chou, E., Oh, J., Kwok, A., Burkin, D. J., & Crosbie, R. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds271 · Cited by 50
Haddix, S. G., Lee, Y. I., Kornegay, J. N., & Thompson, W. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205926 · Cited by 50
δ-Sarcoglycan is required for early zebrafish muscle organization
Guyon, J. R., MOSLEY, A., Jun, S., Montanaro, F., Steffen, L. S., ZHOU, Y., Nigro, V., Zon, L. I., & Kunkel, L. M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.032 · Cited by 50
Peng, J., Redman, C. M., Wu, X., Song, X., Walker, R. H., Westhoff, C. M., & Lee, S. (2007) · Gene · doi:10.1016/j.gene.2006.11.023 · Cited by 50
Le, B. T., Paul, S., Jastrzębska, K., Langer, H., Caruthers, M. H., & Veedu, R. N. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207956119 · Cited by 49
Skeletal and cardiac muscle calcium transport regulation in health and disease
Valentim, M. A., Brahmbhatt, A. N., & Tupling, A. R. (2022) · Bioscience Reports · doi:10.1042/bsr20211997 · Cited by 49
Adult stem cell and mesenchymal progenitor theories of aging
Fukada, S., Ma, Y., & Uezumi, A. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00010 · Cited by 51
Randazzo, D., Khalique, U., Belanto, J. J., Kenea, A., Talsness, D. M., Olthoff, J. T., Tran, M. D., Zaal, K. J. M., Pak, K. S., Pinal‐Fernandez, I., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy418 · Cited by 49
Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse
Sbriccoli, A., Santarelli, M., Carretta, D., Pinto, F., Granato, A., & Minciacchi, D. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12079-j · Cited by 49
Beilharz, M. W., Lareu, R. R., Garrett, K. L., Grounds, M. D., & Fletcher, S. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90029-2 · Cited by 49
Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice
Braun, S., Thioudellet, C., Rodriguez, P., Ali-Hadji, D., Perraud, F., Accart, N., Balloul, J.-M., Halluard, C., Acres, B., Cavallini, B., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301261 · Cited by 49
Brockdorff, N., Fisher, E., Cavanna, J., Lyon, M. F., & Brown, S. D. M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02648.x · Cited by 49
Regulation of myonuclear positioning and muscle function by the skeletal muscle-specific CIP protein
Liu, J., Huang, Z.-P., Nie, M., Wang, G., Silva, W. J., Yang, Q., Freire, P. P., Hu, X., Chen, H., Deng, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922911117 · Cited by 48
Matsumura, C. Y., Taniguti, A. P. T., Pertille, A., Neto, H. S., & Marques, M. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00056.2011 · Cited by 48
Nitahara‐Kasahara, Y., Hayashita‐Kinoh, H., Chiyo, T., Nishiyama, A., Okada, H., Takeda, S., & Okada, T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddu113 · Cited by 51
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
Roberts, T. C., Johansson, H. J., McClorey, G., Godfrey, C., Blomberg, K. E. M., Coursindel, T., Gait, M. J., Smith, C. I. E., Lehtiö, J., Andaloussi, S. E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv381 · Cited by 48
Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions
Saha, M., Mitsuhashi, S., Jones, M. D., Manko, K., Reddy, H. M., Bruels, C. C., Cho, K.-A., Pacak, C. A., Draper, I., & Kang, P. B. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx189 · Cited by 48
The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy
Guiraud, S., Roblin, D., & Kay, D. E. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1438261 · Cited by 48
Time course study of the isometric contractile properties of mdx mouse striated muscles
Pastoret, C., & Sébille, A. (1993) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf00121294 · Cited by 48
Impaired functional and structural recovery after muscle injury in dystrophic mdx mice
Irintchev, A., Zweyer, M., & Wernig, A. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(96)00422-1 · Cited by 48
Welser, J. V., Rooney, J. E., Cohen, N. C., Gurpur, P. B., Singer, C. A., Evans, R. A., Haines, B. A., & Burkin, D. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090052 · Cited by 48
Wolff, A. V., Niday, A. K., Voelker, K. A., Call, J. A., Evans, N. P., Granata, K. P., & Grange, R. W. (2006) · Muscle & Nerve · doi:10.1002/mus.20588 · Cited by 48
Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse
Kurek, J. B., Bower, J. J., Romanella, M., & Austin, L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12802-0 · Cited by 48
L-Type Ca2+ Channel Function Is Linked to Dystrophin Expression in Mammalian Muscle
Friedrich, O., von Wegner, F., Chamberlain, J. S., Fink, R., & Rohrbach, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001762 · Cited by 50
Sanford, J. C., EDWARDS, J., Mays, T. A., GONG, B., Merriam, A. P., & Rafael‐Fortney, J. A. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.025 · Cited by 47
Dissociated flexor digitorum brevis myofiber culture system—A more mature muscle culture system
Ravenscroft, G., Nowak, K. J., Jackaman, C., Clément, S., Lyons, M. A., Gallagher, S., Bakker, A. J., & Laing, N. G. (2007) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20223 · Cited by 47
Sodium is elevated in mdx muscles: Ionic interactions in dystrophic cells
Dunn, J. F., Bannister, N. J., Kemp, G. J., & Publicover, S. J. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90052-z · Cited by 47
Gaschen, F. P., & Burgunder, J. ‐. (2001) · Acta Neuropathologica · doi:10.1007/s004010000299 · Cited by 47
Dubois, C., Figarella-Branger, D. F., Pastoret, C., Rampini, C., Karpati, G., & Rougon, G. N. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90018-3 · Cited by 47
Localization of dystrophin gene transcripts during mouse embryogenesis.
Houzelstein, D., Lyons, G. E., Chamberlain, J. S., & BUCKINGHAM, M. E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.4.811 · Cited by 47
Excitation contraction coupling in normal and mdx mice
Hollingworth, S., Marshall, M. W., & Robson, E. (1990) · Muscle & Nerve · doi:10.1002/mus.880130105 · Cited by 47
Siegel, A. L., Bledsoe, C., Lavin, J., Gatti, F., Berge, J., Millman, G., Turin, E., Winders, W. T., Rutter, J., Palmeiri, B., et al. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.10.006 · Cited by 46
Dubowitz, V. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.801.500 · Cited by 46
Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable
Harper, S. Q. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.16.1807 · Cited by 46
Haws, C. M., & Lansman, J. B. (1991) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1991.0105 · Cited by 46
Bartlett, R. J., Secore, S., Singer, J. T., Bodo, M., Sharma, K. R., & Ricordi, C. (1996) · Cell Transplantation · doi:10.1016/0963-6897(95)02026-8 · Cited by 46
Exercise Is an Adjuvant to Contemporary Dystrophy Treatments
Kostek, M. C., & Gordon, B. S. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000131 · Cited by 45
Zucconi, E., Valadares, M. C., Vieira, N. M., Júnior, C. R. B., Secco, M., Jazedje, T., da Silva, H. C. A., Vainzof, M., & Zatz, M. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.10.011 · Cited by 45
Matsumura, C. Y., de Oliveira, B. M., Durbeej, M., & Marques, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065831 · Cited by 45
Isolation, characterization, and molecular regulation of muscle stem cells
Fukada, S., Ma, Y., Ohtani, T., Watanabe, Y., Murakami, S., & Yamaguchi, M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00317 · Cited by 48
Porcine Models of Muscular Dystrophy
Selsby, J. T., Ross, J. W., Nonneman, D., & Hollinger, K. (2015) · ILAR Journal · doi:10.1093/ilar/ilv015 · Cited by 52
Le, B. T., Adams, A. M., Fletcher, S., Wilton, S. D., & Veedu, R. N. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.09.002 · Cited by 45
Irisin treatment improves healing of dystrophic skeletal muscle
Reza, M. M., Sim, C. M., Subramaniyam, N., Ge, X., Sharma, M., Kambadur, R., & McFarlane, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21636 · Cited by 45
Differential gene expression in skeletal muscle of rats with Vitamin E deficiency
Nier, B. A., Weinberg, P. D., Rimbach, G. H., Stöcklin, E., & Barella, L. (2006) · IUBMB Life · doi:10.1080/15216540600871100 · Cited by 45
Doriguzzi, C., Palmucci, L., Mongini, T., Chiado'-Piat, L., Restagno, G., & Ferrone, M. (1993) · Journal of Neurology · doi:10.1007/bf00838159 · Cited by 45
Expression of mouse agrin in normal, denervated and dystrophic muscle
Eusébio, A. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00036-1 · Cited by 45
Zhang, G., Wooddell, C. I., Hegge, J., Griffin, J. B., Huss, T., Braun, S., & Wolff, J. A. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.133 · Cited by 45
In utero stem cell transplantation.
Flake, A. (2004) · Best Practice & Research: Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.06.006 · Cited by 27
Running endurance abnormality in mdx mice
Hara, H., Nolan, P. M., Scott, M. O., Bućan, M., Wakayama, Y., & Fischbeck, K. H. (2002) · Muscle & Nerve · doi:10.1002/mus.10023 · Cited by 45
Kornegay, J. N., Bogan, J. R., Bogan, D. J., Childers, M. K., & Grange, R. W. (2010) · Methods in molecular biology · doi:10.1007/978-1-61737-982-6_7 · Cited by 45
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
Zhao, J., Zhang, L. J., Mu, X., Doebelin, C., Nguyen, W., Wallace, C. T., Reay, D. P., McGowan, S. J., Corbo, L., Clemens, P. R., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004663 · Cited by 45
Mueller, G. M., O’Day, T., Watchko, J. F., & Ontell, M. (2002) · Human Gene Therapy · doi:10.1089/104303402753812485 · Cited by 45
Wu, B., Cloer, C., Lu, P., Milazi, S., Shaban, M., Shah, S. N., Marston-Poe, L., Moulton, H. M., & Lu, Q. L. (2014) · Gene Therapy · doi:10.1038/gt.2014.53 · Cited by 44
Mu, X., Tang, Y. M., Lu, A., Takayama, K., Ūsas, A., Wang, B., Weiss, K. R., & Huard, J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv055 · Cited by 45
Dubinin, M. V., Talanov, E. Y., Tenkov, K. S., Starinets, V. S., Mikheeva, I. B., & Belosludtsev, K. N. (2020) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148250 · Cited by 44
Differential expression of the skeletal muscle proteome in mdx mice at different ages
Ge, Y., Molloy, M. P., Chamberlain, J. S., & Andrews, P. (2004) · Electrophoresis · doi:10.1002/elps.200406013 · Cited by 44
Approaching a New Age in Duchenne Muscular Dystrophy Treatment
Wagner, K. R. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.013 · Cited by 44
Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice
MacKenzie, T. C., Shaaban, A. F., Radu, A. P., & Flake, A. W. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.33844 · Cited by 44
Seno, M. M. G., Graham, I. R., Athanasopoulos, T., Trollet, C., Pohlschmidt, M., Crompton, M. R., & Dickson, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn162 · Cited by 44
Vetter, T. A., & Townsend, D. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00485.2014 · Cited by 44
Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice
Albesa, M., Ogrodnik, J., Rougier, J., & Abriel, H. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq326 · Cited by 44
Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome
Chamberlain, J. S., Grant, S. G., Reeves, A. A., Mullins, L. J., Stephenson, D. A., Hoffman, E. P., Monaco, A. P., Kunkel, L. M., Caskey, C. T., & Chapman, V. M. (1987) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534487 · Cited by 44
Dallérac, G. M., Perronnet, C., Chagneau, C., Leblanc-Veyrac, P., Samson-Desvignes, N., Peltékian, E., Danos, O., Garcı́a, L., Laroche, S., Billard, J., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.012 · Cited by 43
Use of evans blue dye to compare limb muscles in exercised young and old mdx mice
Wooddell, C. I., Zhang, G., Griffin, J. B., Hegge, J., Huss, T., & Wolff, J. A. (2009) · Muscle & Nerve · doi:10.1002/mus.21527 · Cited by 43
Current advances in cell therapy strategies for muscular dystrophies
Négroni, E., Vallese, D., Vilquin, J., Butler-Browne, G. S., Mouly, V., & Trollet, C. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.542748 · Cited by 45
Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
Nakamura, A. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.57 · Cited by 44
Altered Activity of Signaling Pathways in Diaphragm and Tibialis Anterior Muscle of Dystrophic Mice
Lang, J. M., Esser, K. A., & Dupont‐Versteegden, E. E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900608 · Cited by 43
Dorchies, O. M., Wagner, S., Buetler, T. M., & Rüegg, U. T. (2009) · BioFactors · doi:10.1002/biof.34 · Cited by 43
Dystrophic changes in mdx muscle regenerating from denervation and devascularization
Anderson, J. E. (1991) · Muscle & Nerve · doi:10.1002/mus.880140311 · Cited by 43
Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene
Dickson, G., Love, D. R., Davies, K., Wells, K., Piper, T. A., & Walsh, F. S. (1991) · Human Genetics · doi:10.1007/bf00204929 · Cited by 43
Schmitz, F., Holbach, M., & Drenckhahn, D. (1993) · Histochemistry and Cell Biology · doi:10.1007/bf00267828 · Cited by 43
Selsby, J. T., Acosta, P., Sleeper, M. M., Barton, E. R., & Sweeney, H. L. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00252.2013 · Cited by 42
Localization of dystrophin in the Purkinje cells of normal mice
Huard, J., & Tremblay, J. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90309-u · Cited by 42
Lamina-Associated Polypeptide 2α Loss Impairs Heart Function and Stress Response in Mice
Gotić, I., Leschnik, M. W., Kolm, U., Markovic, M., Haubner, B. J., Biadasiewicz, K., Metzler, B., Stewart, C. L., & Foisner, R. (2009) · Circulation Research · doi:10.1161/circresaha.109.205724 · Cited by 42
Hildyard, J. C. W., Finch, A. M., & Wells, D. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211384 · Cited by 42
SCA-1 micro-heterogeneity in the fate decision of dystrophic fibro/adipogenic progenitors
Giuliani, G., Vumbaca, S., Fuoco, C., Gargioli, C., Giorda, E., Massacci, G., Palma, A., Reggio, A., Riccio, F., Rosina, M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03408-1 · Cited by 46
Vohra, R., Lott, D. J., Mathur, S., Senesac, C., Deol, J. K., Germain, S. A., Bendixen, R. M., Forbes, S. C., Sweeney, H. L., Walter, G. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128915 · Cited by 42
Animal Models of Muscular Dystrophy
Ng, R., Banks, G. B., Hall, J. K., Muir, L. A., Ramos, J. N., Wicki, J., Odom, G. L., Konieczny, P., Seto, J. T., Chamberlain, J. R., et al. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00004-4 · Cited by 46
Metadata
- Authors
- Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J.
- ORCID
- Wight, P A
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1984-02
- Volume
- 81
- Issue
- 4
- Pages
- 1189-1192
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC344791
- OpenAlex
- W2070936696
- Cited by
- 1,765
- References
- 17
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 54 · 2021: 60 · 2020: 65 · 2019: 38 · 2018: 68 · 2017: 60 · 2016: 54 · 2015: 78 · 2014: 79 · 2013: 58 · 2012: 65
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked muscular dystrophy, Duchenne muscular dystrophy, muscle creatine kinase, pyruvate kinase, X chromosome mapping, gene order
- MeSH terms
- Animals, Crosses, Genetic, Female, Genetic Linkage, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Muscles, Muscular Dystrophy, Animal, Mutation, Pyruvate Kinase, X Chromosome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review